… impact of intravenous bevacizumab on a child with severe laryngotracheal and pulmonary
papillomatosis.5 Since adjuvant therapy with systemic bevacizumab became recognized as a …

… and distal airway involvement. Thus, systemic administration of bevacizumab for aggressive
… The objective of this systematic review on systemic bevacizumab treatment for JORRP was …

… patients suggests that systemic bevacizumab presents a … lesions, lung parenchyma
involvement, papillomas of the … These findings indicate that systemic bevacizumab treatment …

… Seven patients with JO-RRP at our institution have been treated with systemic bevacizumab
since 2015. The baseline characteristics of each patient are presented in Table I. The …

… In 95% of the patients treated with systemic bevacizumab, the post-bevacizumab surgical …
bevacizumab showed a lower efficacy: in 62% of the patients, the post-bevacizumab surgical …

… The purpose of this study is to develop consensus on key points that would support the use
of systemic bevacizumab for the treatment of recurrent respiratory papillomatosis (RRP), and …

… of pulmonary RRP patients receiving systemic bevacizumab, and show that systemic
bevacizumab … inducing a stable-to-partial treatment response for pulmonary RRP. As patients with …

… bevacizumab. (A) Case 2: CT image of the upper lung fields prior to initiation of systemic
bevacizumab … of the lower lung fields prior to initiation of systemic bevacizumab treatment. (C) …

… of our systemic bevacizumab … of systemic bevacizumab and comprehensive treatment on
RRP patients, encompassing different age group and varying disease severities. Bevacizumab …

… systemic bevacizumab in five patients with RRP [5]. In 2016, Zur and Fox described the use
of systemic bevacizumab … to describe the use of intravenous bevacizumab for the treatment of …